Literature DB >> 11581601

The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications.

J S Wang1, D Shum-Tim, E Chedrawy, R C Chiu.   

Abstract

OBJECTIVES: Bone marrow stromal cells contain "adult stem cells." We tested the hypothesis that coronary-infused bone marrow stromal cells may populate the infarcted heart and undergo milieu-dependent differentiation to regenerate functional tissues with different phenotypic features.
METHODS: Isogenic adult rats were used as donors and recipients to simulate autologous transplantation clinically. Myocardial infarction was created by proximal occlusion of left coronary artery in 12 recipient rats. Isolated bone marrow stromal cells were purified, expanded, and retrovirally transduced with LacZ reporter gene for cell labeling. Stromal cells were then infused into the briefly distally clamped ascending aorta of recipient rats 2 weeks after left coronary artery ligation. The hearts were harvested immediately (n = 2) or 4 weeks (n = 10) later to trace the implanted cells and identify their phenotypes.
RESULTS: Viable cells labeled with LacZ reporter gene were identified in 8 recipient hearts. Immediately after cell infusion, the labeled cells were trapped within the coronary capillaries. After 4 weeks, they could be detected individually or in clusters within myocardial scar expressing fibroblastic phenotype or outside the infarction area with morphologic features of normal cardiomyocytes. Some were incorporated into endocardium and capillary endothelium.
CONCLUSIONS: Our findings suggest that bone marrow stromal cells can traffic through the coronary system to the injured heart and form cardiomyocytes or fibroblasts, depending on the specific microenvironment. Endothelial progenitor cells in the stromal cell population may be involved in the postinfarction neovascularization process. Whether therapeutic use of bone marrow stromal cells can improve the myocardial healing and remodeling process after infarction is worthy of further investigation.

Entities:  

Mesh:

Year:  2001        PMID: 11581601     DOI: 10.1067/mtc.2001.116317

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  32 in total

Review 1.  Bone-marrow stem cells as a source for cell therapy.

Authors:  Ray C-J Chiu
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

2.  Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells.

Authors:  Jonathan M Hill; Alexander J Dick; Venkatesh K Raman; Richard B Thompson; Zu-Xi Yu; K Allison Hinds; Breno S S Pessanha; Michael A Guttman; Timothy R Varney; Bradley J Martin; Cynthia E Dunbar; Elliot R McVeigh; Robert J Lederman
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

Review 3.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 4.  Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation.

Authors:  Paolo Angelini; Roger R Markwald
Journal:  Tex Heart Inst J       Date:  2005

5.  Milieu-based versus gene-modulatory strategies for directing stem cell differentiation--A major issue of contention in transplantation medicine.

Authors:  Boon Chin Heng; Tong Cao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

Review 6.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

7.  The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning.

Authors:  Aina He; Yun Jiang; Chun Gui; Yong Sun; Jiahui Li; Jian-an Wang
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

8.  Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine.

Authors:  Alexander J Dick; Michael A Guttman; Venkatesh K Raman; Dana C Peters; Breno S S Pessanha; Jonathan M Hill; Scott Smith; Greig Scott; Elliot R McVeigh; Robert J Lederman
Journal:  Circulation       Date:  2003-12-01       Impact factor: 29.690

9.  Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro.

Authors:  Svetlana Mastitskaya; Bernd Denecke
Journal:  J Negat Results Biomed       Date:  2009-11-10

10.  Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction.

Authors:  Gerald Wisenberg; Katie Lekx; Pam Zabel; Huafu Kong; Rupinder Mann; Peter R Zeman; Sudip Datta; Caroline N Culshaw; Peter Merrifield; Yves Bureau; Glenn Wells; Jane Sykes; Frank S Prato
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-27       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.